Finasteride, a Type 2 5-reductase inhibitor, in the treatment of men with androgenetic alopecia

ISSN： 1354-3784

Source： Expert Opinion on Investigational Drugs, Vol.8, Iss.4, 1999-04, pp. : 403-415

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Finasteride in the treatment of alopecia

By Libecco James F Bergfeld Wilma F

Expert Opinion on Pharmacotherapy, Vol. 5, Iss. 4, 2004-04 ,pp. : 933-940

Informa Healthcare

Access to resources Recommend Favorite

Dutasteride in Androgenetic Alopecia: An Update

Current Clinical Pharmacology, Vol. 12, Iss. 1, 2017-06 ,pp. : 31-35

Bentham Science Publishers

Access to resources Recommend Favorite

New investigational drugs for androgenetic alopecia

By Valente Duarte de Sousa Isabel Cristina Tosti Antonella

Expert Opinion on Investigational Drugs, Vol. 22, Iss. 5, 2013-05 ,pp. : 573-589

Informa Healthcare

Access to resources Recommend Favorite

Evidence-based therapy of androgenetic alopecia

By Wolff Hans

PHARMAKON, Vol. 2, Iss. 3, 2014-05 ,pp. : 183-186

Govi-Verlag

Access to resources Recommend Favorite

Once-daily treatment with minoxidil and tretinoin is as effective as twice-daily minoxidil alone for androgenetic alopecia

Inpharma, Vol. 1, Iss. 1610, 2007-01 ,pp. : 18-18

Adis International

Access to resources Recommend Favorite